

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 7.21018703 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.46663285 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.06081839 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06081839 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.80709055 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.74299836 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.74299836 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.50539457 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.36093300 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.21290076 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 5.13073641 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.09068003 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.88308772 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.87741914 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.82822690 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78141037 |
| 17 | postsynaptic membrane organization (GO:0001941) | 4.74488444 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.73108259 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.72604734 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.71575468 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.71575468 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.71575468 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.71511227 |
| 24 | vocalization behavior (GO:0071625) | 4.67612607 |
| 25 | cerebellar granule cell differentiation (GO:0021707) | 4.56045200 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.54181166 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.53324755 |
| 28 | protein localization to synapse (GO:0035418) | 4.50513423 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.47045658 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.43614801 |
| 31 | sodium ion export (GO:0071436) | 4.42745535 |
| 32 | urea cycle (GO:0000050) | 4.38656252 |
| 33 | urea metabolic process (GO:0019627) | 4.38656252 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.36062984 |
| 35 | positive regulation of synapse maturation (GO:0090129) | 4.34383086 |
| 36 | glyoxylate metabolic process (GO:0046487) | 4.33006070 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 4.30930380 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 4.30187637 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 4.27467390 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.25646095 |
| 41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.20008640 |
| 42 | neuronal action potential propagation (GO:0019227) | 4.17740706 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16691542 |
| 44 | protein carboxylation (GO:0018214) | 4.16691542 |
| 45 | exploration behavior (GO:0035640) | 4.14485691 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 4.14139193 |
| 47 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.13205682 |
| 48 | bile acid metabolic process (GO:0008206) | 4.09828324 |
| 49 | complement activation, alternative pathway (GO:0006957) | 4.09354418 |
| 50 | neuronal ion channel clustering (GO:0045161) | 4.04548139 |
| 51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.04314600 |
| 52 | cell migration in hindbrain (GO:0021535) | 4.04024486 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.03786173 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.02935013 |
| 55 | reverse cholesterol transport (GO:0043691) | 4.02780066 |
| 56 | positive regulation of dendritic spine development (GO:0060999) | 3.99529599 |
| 57 | regulation of complement activation (GO:0030449) | 3.96068770 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.95190592 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95005498 |
| 60 | cysteine metabolic process (GO:0006534) | 3.94460820 |
| 61 | sulfur amino acid catabolic process (GO:0000098) | 3.93938189 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.93893413 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.93893413 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.93893413 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 3.93693124 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.90456875 |
| 67 | neuron cell-cell adhesion (GO:0007158) | 3.88033826 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 3.87676728 |
| 69 | neurotransmitter transport (GO:0006836) | 3.85874046 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.84544415 |
| 71 | tyrosine metabolic process (GO:0006570) | 3.83300482 |
| 72 | auditory behavior (GO:0031223) | 3.81754049 |
| 73 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.79735283 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.77880791 |
| 75 | positive regulation of membrane potential (GO:0045838) | 3.77129615 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 3.76331965 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 3.75635981 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 3.74972265 |
| 79 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.74883624 |
| 80 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74314039 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 3.73160363 |
| 82 | negative regulation of sterol transport (GO:0032372) | 3.67455913 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 3.67455913 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.67177067 |
| 85 | layer formation in cerebral cortex (GO:0021819) | 3.66513952 |
| 86 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.65567594 |
| 87 | glutamate metabolic process (GO:0006536) | 3.62442324 |
| 88 | glutamate secretion (GO:0014047) | 3.61086990 |
| 89 | phospholipid efflux (GO:0033700) | 3.60696830 |
| 90 | regulation of synapse maturation (GO:0090128) | 3.60475693 |
| 91 | alpha-amino acid catabolic process (GO:1901606) | 3.59713320 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.58165883 |
| 93 | acylglycerol homeostasis (GO:0055090) | 3.57815959 |
| 94 | triglyceride homeostasis (GO:0070328) | 3.57815959 |
| 95 | cholesterol efflux (GO:0033344) | 3.56283780 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55400925 |
| 97 | regulation of vesicle fusion (GO:0031338) | 3.53381077 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.53361914 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 3.52520645 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.52287958 |
| 101 | regulation of postsynaptic membrane potential (GO:0060078) | 3.52064723 |
| 102 | lysine catabolic process (GO:0006554) | 3.51248751 |
| 103 | lysine metabolic process (GO:0006553) | 3.51248751 |
| 104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.51125753 |
| 105 | L-amino acid import (GO:0043092) | 3.50505042 |
| 106 | regulation of neurotransmitter levels (GO:0001505) | 3.50203267 |
| 107 | neuromuscular synaptic transmission (GO:0007274) | 3.48852726 |
| 108 | ketone body metabolic process (GO:1902224) | 3.47166456 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 3.44675165 |
| 110 | neuromuscular process controlling balance (GO:0050885) | 3.43669030 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 3.43421792 |
| 112 | bile acid and bile salt transport (GO:0015721) | 3.42963780 |
| 113 | presynaptic membrane organization (GO:0097090) | 3.41812093 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 3.40826319 |
| 115 | homocysteine metabolic process (GO:0050667) | 3.38834602 |
| 116 | amino-acid betaine metabolic process (GO:0006577) | 3.38714488 |
| 117 | axonal fasciculation (GO:0007413) | 3.37404022 |
| 118 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.36654220 |
| 119 | regulation of synaptic plasticity (GO:0048167) | 3.36188762 |
| 120 | neuron recognition (GO:0008038) | 3.35413477 |
| 121 | membrane depolarization (GO:0051899) | 3.33368131 |
| 122 | presynaptic membrane assembly (GO:0097105) | 3.33315486 |
| 123 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.32629358 |
| 124 | drug catabolic process (GO:0042737) | 3.30965113 |
| 125 | transmission of nerve impulse (GO:0019226) | 3.30353666 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 3.30334552 |
| 127 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29333871 |
| 128 | low-density lipoprotein particle remodeling (GO:0034374) | 3.29139982 |
| 129 | long-term memory (GO:0007616) | 3.28876935 |
| 130 | cellular amino acid catabolic process (GO:0009063) | 3.28651630 |
| 131 | cellular modified amino acid catabolic process (GO:0042219) | 3.28514936 |
| 132 | potassium ion homeostasis (GO:0055075) | 3.28275581 |
| 133 | indolalkylamine metabolic process (GO:0006586) | 3.27522728 |
| 134 | cellular glucuronidation (GO:0052695) | 3.25791489 |
| 135 | dendritic spine organization (GO:0097061) | 3.24815184 |
| 136 | plasma lipoprotein particle clearance (GO:0034381) | 3.23658401 |
| 137 | imidazole-containing compound metabolic process (GO:0052803) | 3.22802927 |
| 138 | cell differentiation in hindbrain (GO:0021533) | 3.21855829 |
| 139 | cofactor catabolic process (GO:0051187) | 3.20849107 |
| 140 | amine catabolic process (GO:0009310) | 3.20570510 |
| 141 | cellular biogenic amine catabolic process (GO:0042402) | 3.20570510 |
| 142 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20148725 |
| 143 | regulation of dendritic spine development (GO:0060998) | 3.19991959 |
| 144 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.18399760 |
| 145 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.17305922 |
| 146 | potassium ion import (GO:0010107) | 3.16723198 |
| 147 | fibrinolysis (GO:0042730) | 3.13497934 |
| 148 | arginine metabolic process (GO:0006525) | 3.12444103 |
| 149 | amino acid import (GO:0043090) | 3.12413172 |
| 150 | response to auditory stimulus (GO:0010996) | 3.12318838 |
| 151 | cell communication by electrical coupling (GO:0010644) | 3.11680067 |
| 152 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.10683459 |
| 153 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.10603047 |
| 154 | aldehyde catabolic process (GO:0046185) | 3.10415513 |
| 155 | central nervous system myelination (GO:0022010) | 3.09432262 |
| 156 | axon ensheathment in central nervous system (GO:0032291) | 3.09432262 |
| 157 | positive regulation of lipid catabolic process (GO:0050996) | 3.04900558 |
| 158 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04495715 |
| 159 | regulation of bile acid biosynthetic process (GO:0070857) | 3.03038261 |
| 160 | adult walking behavior (GO:0007628) | 3.00810564 |
| 161 | regulation of synaptic transmission (GO:0050804) | 2.99979731 |
| 162 | cytolysis (GO:0019835) | 2.99731576 |
| 163 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.99171709 |
| 164 | blood coagulation, intrinsic pathway (GO:0007597) | 2.98981117 |
| 165 | negative regulation of lipase activity (GO:0060192) | 2.98189454 |
| 166 | proline transport (GO:0015824) | 2.97607665 |
| 167 | mating behavior (GO:0007617) | 2.97296700 |
| 168 | synaptic transmission (GO:0007268) | 2.97179486 |
| 169 | indole-containing compound metabolic process (GO:0042430) | 2.97014098 |
| 170 | plasma lipoprotein particle assembly (GO:0034377) | 2.96521893 |
| 171 | complement activation, classical pathway (GO:0006958) | 2.95722076 |
| 172 | exogenous drug catabolic process (GO:0042738) | 2.95615395 |
| 173 | uronic acid metabolic process (GO:0006063) | 2.95596269 |
| 174 | glucuronate metabolic process (GO:0019585) | 2.95596269 |
| 175 | opsonization (GO:0008228) | 2.92908919 |
| 176 | mechanosensory behavior (GO:0007638) | 2.91218609 |
| 177 | establishment of synaptic vesicle localization (GO:0097480) | 2.90057095 |
| 178 | synaptic vesicle transport (GO:0048489) | 2.90057095 |
| 179 | neuromuscular process (GO:0050905) | 2.89866852 |
| 180 | cellular sodium ion homeostasis (GO:0006883) | 2.89412639 |
| 181 | ethanol oxidation (GO:0006069) | 2.88920846 |
| 182 | establishment of mitochondrion localization (GO:0051654) | 2.88792386 |
| 183 | complement activation (GO:0006956) | 2.88504251 |
| 184 | acetyl-CoA metabolic process (GO:0006084) | 2.87421196 |
| 185 | aspartate family amino acid catabolic process (GO:0009068) | 2.86897044 |
| 186 | protein activation cascade (GO:0072376) | 2.86395823 |
| 187 | phospholipid homeostasis (GO:0055091) | 2.85894006 |
| 188 | synaptic vesicle exocytosis (GO:0016079) | 2.84658536 |
| 189 | short-chain fatty acid metabolic process (GO:0046459) | 2.84654823 |
| 190 | plasma lipoprotein particle organization (GO:0071827) | 2.84169130 |
| 191 | dendrite morphogenesis (GO:0048813) | 2.81962030 |
| 192 | steroid catabolic process (GO:0006706) | 2.80723116 |
| 193 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.79970097 |
| 194 | negative regulation of complement activation (GO:0045916) | 2.79901955 |
| 195 | organic acid catabolic process (GO:0016054) | 2.79739204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.84520735 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.72532924 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.77290509 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68696741 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.58367017 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31932519 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16899983 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12435083 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.61775433 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47891765 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36755944 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25668912 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.22575617 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21607925 |
| 15 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16314213 |
| 16 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.14811476 |
| 17 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.92956299 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.87710248 |
| 19 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84208153 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.83376187 |
| 21 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78751126 |
| 22 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76081727 |
| 23 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76081727 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75038463 |
| 25 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.73985552 |
| 26 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73005342 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72990245 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72613427 |
| 29 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64211541 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63092071 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62890673 |
| 32 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.62719159 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.60721492 |
| 34 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60454446 |
| 35 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59309802 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57545656 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52683879 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47837678 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47199565 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44350958 |
| 41 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.43007241 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40625268 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39135353 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38132168 |
| 45 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37638187 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37237706 |
| 47 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36414011 |
| 48 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36164448 |
| 49 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35962379 |
| 50 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34862298 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33102686 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33042112 |
| 53 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.31135821 |
| 54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25419785 |
| 55 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.24298914 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24249570 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23545647 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22520709 |
| 59 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21583895 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21061837 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21003852 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19844729 |
| 63 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18616986 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17695488 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17401987 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15366064 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13104754 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13003828 |
| 69 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12693931 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11517481 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11161437 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11161437 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10988190 |
| 74 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.09670945 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08905065 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08225144 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07862584 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06175572 |
| 79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06054406 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03694516 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01977998 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00509735 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99486033 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99064653 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98930655 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97746341 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96898161 |
| 88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95907154 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93968424 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92710351 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90442962 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90391851 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90294166 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89343043 |
| 95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87317425 |
| 96 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87162375 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86876466 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86349597 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86088607 |
| 100 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85664951 |
| 101 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84988682 |
| 102 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84721979 |
| 103 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84721979 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83974939 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83766642 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83399708 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83071354 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81566165 |
| 109 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81229268 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80617809 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.80533006 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80078301 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 0.80077526 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80019508 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79778021 |
| 116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79487008 |
| 117 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79445526 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78595720 |
| 119 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.78552542 |
| 120 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78157811 |
| 121 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77737639 |
| 122 | JUN_21703547_ChIP-Seq_K562_Human | 0.77292311 |
| 123 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76573357 |
| 124 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.76471333 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76467827 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75154104 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75003014 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.75003014 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74535312 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74508482 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.74278706 |
| 132 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.74210077 |
| 133 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 0.74042883 |
| 134 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.73670634 |
| 135 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.73546380 |
| 136 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.72553303 |
| 137 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.72063134 |
| 138 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.71953358 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71870257 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71270207 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70821312 |
| 142 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.70522463 |
| 143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.70119963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.50439128 |
| 2 | MP0005360_urolithiasis | 5.79131741 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.05998570 |
| 4 | MP0005365_abnormal_bile_salt | 4.66822235 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.25495761 |
| 6 | MP0003880_abnormal_central_pattern | 3.57367693 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.31742204 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.95118236 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.82440288 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.68330918 |
| 11 | MP0002736_abnormal_nociception_after | 2.64763641 |
| 12 | MP0003252_abnormal_bile_duct | 2.57627884 |
| 13 | MP0005083_abnormal_biliary_tract | 2.54530309 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.48972864 |
| 15 | MP0003195_calcinosis | 2.40467121 |
| 16 | MP0004270_analgesia | 2.30564267 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.13387520 |
| 18 | MP0005332_abnormal_amino_acid | 2.05116316 |
| 19 | MP0009840_abnormal_foam_cell | 1.94716355 |
| 20 | MP0009745_abnormal_behavioral_response | 1.93604146 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.82661196 |
| 22 | MP0002063_abnormal_learning/memory/cond | 1.79549862 |
| 23 | MP0003329_amyloid_beta_deposits | 1.75934714 |
| 24 | MP0002064_seizures | 1.75786873 |
| 25 | MP0003868_abnormal_feces_composition | 1.70047543 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.67206156 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.63010293 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.62573660 |
| 29 | MP0004885_abnormal_endolymph | 1.57227009 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.53097723 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.50524711 |
| 32 | MP0000604_amyloidosis | 1.50291329 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.49112832 |
| 34 | MP0003787_abnormal_imprinting | 1.48478732 |
| 35 | MP0002272_abnormal_nervous_system | 1.43993915 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.41454695 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.41423502 |
| 38 | MP0009046_muscle_twitch | 1.40983868 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.38064187 |
| 40 | MP0003122_maternal_imprinting | 1.37556224 |
| 41 | MP0004742_abnormal_vestibular_system | 1.36374715 |
| 42 | MP0000609_abnormal_liver_physiology | 1.35381651 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.32718330 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.31924265 |
| 45 | MP0009697_abnormal_copulation | 1.28577017 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.28457214 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.25264490 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23239801 |
| 49 | MP0001970_abnormal_pain_threshold | 1.23024938 |
| 50 | MP0001188_hyperpigmentation | 1.19498731 |
| 51 | MP0002152_abnormal_brain_morphology | 1.17913558 |
| 52 | MP0001529_abnormal_vocalization | 1.16336097 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.16213141 |
| 54 | MP0002822_catalepsy | 1.15903342 |
| 55 | MP0003879_abnormal_hair_cell | 1.15638371 |
| 56 | MP0003283_abnormal_digestive_organ | 1.14964612 |
| 57 | MP0001177_atelectasis | 1.13488680 |
| 58 | MP0005535_abnormal_body_temperature | 1.12724846 |
| 59 | MP0004858_abnormal_nervous_system | 1.12637089 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.12480095 |
| 61 | MP0001764_abnormal_homeostasis | 1.11934181 |
| 62 | MP0003123_paternal_imprinting | 1.11033596 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.10444369 |
| 64 | MP0008874_decreased_physiological_sensi | 1.08545860 |
| 65 | MP0001486_abnormal_startle_reflex | 1.04484340 |
| 66 | MP0000920_abnormal_myelination | 1.02877925 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.02323723 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.01615021 |
| 69 | MP0001984_abnormal_olfaction | 0.99892533 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.99737236 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.99417604 |
| 72 | MP0003633_abnormal_nervous_system | 0.96268055 |
| 73 | MP0008872_abnormal_physiological_respon | 0.94081137 |
| 74 | MP0002184_abnormal_innervation | 0.90693787 |
| 75 | MP0003634_abnormal_glial_cell | 0.87739624 |
| 76 | MP0005423_abnormal_somatic_nervous | 0.87394683 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.86413040 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.85337756 |
| 79 | MP0004130_abnormal_muscle_cell | 0.84006852 |
| 80 | MP0005386_behavior/neurological_phenoty | 0.83700201 |
| 81 | MP0004924_abnormal_behavior | 0.83700201 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.81884141 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.81728808 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.81581642 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.81348008 |
| 86 | MP0004811_abnormal_neuron_physiology | 0.80993003 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.79851417 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.79138719 |
| 89 | MP0003632_abnormal_nervous_system | 0.78464821 |
| 90 | MP0005647_abnormal_sex_gland | 0.78090484 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.77519376 |
| 92 | MP0005499_abnormal_olfactory_system | 0.77454899 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.77454899 |
| 94 | MP0003631_nervous_system_phenotype | 0.77337626 |
| 95 | MP0005409_darkened_coat_color | 0.74741936 |
| 96 | MP0003861_abnormal_nervous_system | 0.74413343 |
| 97 | MP0002557_abnormal_social/conspecific_i | 0.74331635 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.73790478 |
| 99 | MP0005670_abnormal_white_adipose | 0.73606033 |
| 100 | MP0004142_abnormal_muscle_tone | 0.73016190 |
| 101 | MP0000026_abnormal_inner_ear | 0.72131387 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.72066685 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.71880359 |
| 104 | MP0002066_abnormal_motor_capabilities/c | 0.70844903 |
| 105 | MP0000778_abnormal_nervous_system | 0.70000357 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.69597314 |
| 107 | MP0003690_abnormal_glial_cell | 0.69369867 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.69010078 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.68543726 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.68388099 |
| 111 | MP0001905_abnormal_dopamine_level | 0.68330616 |
| 112 | MP0003121_genomic_imprinting | 0.67900032 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.67375997 |
| 114 | MP0009379_abnormal_foot_pigmentation | 0.66983695 |
| 115 | MP0005448_abnormal_energy_balance | 0.66773420 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.66467389 |
| 117 | MP0000955_abnormal_spinal_cord | 0.66162059 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.62979140 |
| 119 | MP0000534_abnormal_ureter_morphology | 0.62968915 |
| 120 | MP0000566_synostosis | 0.62230457 |
| 121 | MP0002653_abnormal_ependyma_morphology | 0.62033935 |
| 122 | MP0003075_altered_response_to | 0.61865025 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.60926213 |
| 124 | MP0000751_myopathy | 0.58938624 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.57997919 |
| 126 | MP0010769_abnormal_survival | 0.57956212 |
| 127 | MP0001943_abnormal_respiration | 0.57571968 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.56874124 |
| 129 | MP0005187_abnormal_penis_morphology | 0.56040224 |
| 130 | MP0004145_abnormal_muscle_electrophysio | 0.55713987 |
| 131 | MP0002082_postnatal_lethality | 0.55591767 |
| 132 | MP0010770_preweaning_lethality | 0.55591767 |
| 133 | MP0002229_neurodegeneration | 0.55425098 |
| 134 | MP0004147_increased_porphyrin_level | 0.55080589 |
| 135 | MP0010768_mortality/aging | 0.54834835 |
| 136 | MP0004085_abnormal_heartbeat | 0.54571449 |
| 137 | MP0002882_abnormal_neuron_morphology | 0.54297678 |
| 138 | MP0000598_abnormal_liver_morphology | 0.54045606 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.53268223 |
| 140 | MP0003011_delayed_dark_adaptation | 0.53013941 |
| 141 | MP0009764_decreased_sensitivity_to | 0.52528216 |
| 142 | MP0004883_abnormal_blood_vessel | 0.52026242 |
| 143 | MP0003953_abnormal_hormone_level | 0.51479272 |
| 144 | MP0005334_abnormal_fat_pad | 0.51140184 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.50065788 |
| 146 | MP0008569_lethality_at_weaning | 0.49988082 |
| 147 | MP0002090_abnormal_vision | 0.49352239 |
| 148 | MP0005166_decreased_susceptibility_to | 0.48384439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.24719227 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.97375012 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.59569073 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.33882080 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.26032312 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.07012281 |
| 7 | Xanthomatosis (HP:0000991) | 4.98195946 |
| 8 | Abnormality of binocular vision (HP:0011514) | 4.80770561 |
| 9 | Diplopia (HP:0000651) | 4.80770561 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.57806170 |
| 11 | Focal motor seizures (HP:0011153) | 4.48368536 |
| 12 | Complement deficiency (HP:0004431) | 4.27259159 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 4.12267910 |
| 14 | Hyperventilation (HP:0002883) | 3.89094319 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.80077218 |
| 16 | Myokymia (HP:0002411) | 3.78330434 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.65626473 |
| 18 | Limb dystonia (HP:0002451) | 3.60069832 |
| 19 | Joint hemorrhage (HP:0005261) | 3.53614086 |
| 20 | Epidermoid cyst (HP:0200040) | 3.53146769 |
| 21 | Ankle clonus (HP:0011448) | 3.51960530 |
| 22 | Hyperglycinemia (HP:0002154) | 3.50876720 |
| 23 | Hyperammonemia (HP:0001987) | 3.47548022 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47166081 |
| 25 | Ketosis (HP:0001946) | 3.42457388 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36674998 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.36097004 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.33657230 |
| 29 | Postural instability (HP:0002172) | 3.32150932 |
| 30 | Neurofibrillary tangles (HP:0002185) | 3.31851479 |
| 31 | Genetic anticipation (HP:0003743) | 3.25675996 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.25467227 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.25434577 |
| 34 | Obstructive sleep apnea (HP:0002870) | 3.24126725 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16646485 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16283629 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.15340325 |
| 38 | Cholecystitis (HP:0001082) | 3.12328390 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 3.12328390 |
| 40 | Spastic gait (HP:0002064) | 3.12036964 |
| 41 | Focal seizures (HP:0007359) | 3.09854392 |
| 42 | Spontaneous abortion (HP:0005268) | 3.07934724 |
| 43 | Fat malabsorption (HP:0002630) | 3.06730140 |
| 44 | Atonic seizures (HP:0010819) | 3.03725157 |
| 45 | Truncal ataxia (HP:0002078) | 2.97934381 |
| 46 | Papilledema (HP:0001085) | 2.93307075 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.91873144 |
| 48 | Abnormality of complement system (HP:0005339) | 2.90567576 |
| 49 | Status epilepticus (HP:0002133) | 2.86239377 |
| 50 | Annular pancreas (HP:0001734) | 2.82097938 |
| 51 | Dysmetria (HP:0001310) | 2.76053641 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 2.75809097 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.75809097 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.69948943 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.69912680 |
| 56 | Hemiparesis (HP:0001269) | 2.67206861 |
| 57 | Hyperglycinuria (HP:0003108) | 2.65933314 |
| 58 | Mutism (HP:0002300) | 2.64541012 |
| 59 | Absence seizures (HP:0002121) | 2.64142265 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.63767364 |
| 61 | Sleep apnea (HP:0010535) | 2.60947408 |
| 62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58933642 |
| 63 | Cerebral hypomyelination (HP:0006808) | 2.56613492 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.55144279 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.54666662 |
| 66 | Neonatal onset (HP:0003623) | 2.52614357 |
| 67 | Skin nodule (HP:0200036) | 2.51855290 |
| 68 | Anxiety (HP:0000739) | 2.51081905 |
| 69 | Ketoacidosis (HP:0001993) | 2.50817268 |
| 70 | Dialeptic seizures (HP:0011146) | 2.50363570 |
| 71 | Hemiplegia (HP:0002301) | 2.50203406 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.49018121 |
| 73 | Cholelithiasis (HP:0001081) | 2.48985046 |
| 74 | Cerebral edema (HP:0002181) | 2.48680053 |
| 75 | Depression (HP:0000716) | 2.45992012 |
| 76 | Intention tremor (HP:0002080) | 2.43803249 |
| 77 | Abnormality of the corticospinal tract (HP:0002492) | 2.43636617 |
| 78 | Febrile seizures (HP:0002373) | 2.41980860 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.40993669 |
| 80 | Polyphagia (HP:0002591) | 2.39880172 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.39401269 |
| 82 | Delusions (HP:0000746) | 2.35984269 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.35910710 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.35286512 |
| 85 | Lower limb muscle weakness (HP:0007340) | 2.34424475 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 2.34361304 |
| 87 | Visual hallucinations (HP:0002367) | 2.33946381 |
| 88 | Bradykinesia (HP:0002067) | 2.32255558 |
| 89 | Metabolic acidosis (HP:0001942) | 2.31224562 |
| 90 | Mitral stenosis (HP:0001718) | 2.30689696 |
| 91 | Broad-based gait (HP:0002136) | 2.30653318 |
| 92 | Urinary urgency (HP:0000012) | 2.30193954 |
| 93 | Dysdiadochokinesis (HP:0002075) | 2.29029101 |
| 94 | Drooling (HP:0002307) | 2.28945790 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 2.28417883 |
| 96 | Insomnia (HP:0100785) | 2.27355366 |
| 97 | Insidious onset (HP:0003587) | 2.22982022 |
| 98 | Termporal pattern (HP:0011008) | 2.22982022 |
| 99 | Hypoglycemic coma (HP:0001325) | 2.22442632 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21681878 |
| 101 | Myotonia (HP:0002486) | 2.21016118 |
| 102 | Akinesia (HP:0002304) | 2.19703124 |
| 103 | Lethargy (HP:0001254) | 2.19378626 |
| 104 | Fair hair (HP:0002286) | 2.16319990 |
| 105 | Peripheral hypomyelination (HP:0007182) | 2.15300893 |
| 106 | Steatorrhea (HP:0002570) | 2.15256608 |
| 107 | Acanthocytosis (HP:0001927) | 2.14759510 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 2.14576594 |
| 109 | Gout (HP:0001997) | 2.13445475 |
| 110 | Incomplete penetrance (HP:0003829) | 2.12723074 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12084376 |
| 112 | Stereotypic behavior (HP:0000733) | 2.07857203 |
| 113 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07019816 |
| 114 | Hypsarrhythmia (HP:0002521) | 2.06336754 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06096880 |
| 116 | Excessive salivation (HP:0003781) | 2.05860062 |
| 117 | Prolonged QT interval (HP:0001657) | 2.03468952 |
| 118 | Dysmetric saccades (HP:0000641) | 2.03265021 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 2.01108646 |
| 120 | Irritability (HP:0000737) | 2.00845957 |
| 121 | Torticollis (HP:0000473) | 1.99771958 |
| 122 | Clonus (HP:0002169) | 1.98738580 |
| 123 | Craniofacial dystonia (HP:0012179) | 1.97869622 |
| 124 | Action tremor (HP:0002345) | 1.97858115 |
| 125 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97810925 |
| 126 | Epileptiform EEG discharges (HP:0011182) | 1.97409513 |
| 127 | Progressive cerebellar ataxia (HP:0002073) | 1.97276629 |
| 128 | Megalencephaly (HP:0001355) | 1.96872311 |
| 129 | Focal dystonia (HP:0004373) | 1.96580418 |
| 130 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.93358040 |
| 131 | Pheochromocytoma (HP:0002666) | 1.92650392 |
| 132 | Amblyopia (HP:0000646) | 1.90945133 |
| 133 | Abnormality of purine metabolism (HP:0004352) | 1.90793233 |
| 134 | Rigidity (HP:0002063) | 1.90599603 |
| 135 | Abnormality of saccadic eye movements (HP:0000570) | 1.90225575 |
| 136 | Amyloidosis (HP:0011034) | 1.90090417 |
| 137 | Hepatocellular carcinoma (HP:0001402) | 1.88993004 |
| 138 | Impaired social interactions (HP:0000735) | 1.88471149 |
| 139 | Abnormal social behavior (HP:0012433) | 1.88471149 |
| 140 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88297660 |
| 141 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88297660 |
| 142 | Hypoventilation (HP:0002791) | 1.87281483 |
| 143 | Cerebral inclusion bodies (HP:0100314) | 1.87171191 |
| 144 | Retinal dysplasia (HP:0007973) | 1.86008115 |
| 145 | Aplasia involving bones of the extremities (HP:0009825) | 1.85865349 |
| 146 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85865349 |
| 147 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85865349 |
| 148 | Apathy (HP:0000741) | 1.85164089 |
| 149 | Poor eye contact (HP:0000817) | 1.84723528 |
| 150 | Spastic tetraparesis (HP:0001285) | 1.84542291 |
| 151 | Turricephaly (HP:0000262) | 1.84255736 |
| 152 | Myocardial infarction (HP:0001658) | 1.83702129 |
| 153 | Vascular calcification (HP:0004934) | 1.83658181 |
| 154 | Abnormality of the Achilles tendon (HP:0005109) | 1.82085175 |
| 155 | Vomiting (HP:0002013) | 1.81818518 |
| 156 | Malnutrition (HP:0004395) | 1.80659901 |
| 157 | Abnormality of pain sensation (HP:0010832) | 1.79437846 |
| 158 | Impaired pain sensation (HP:0007328) | 1.79437846 |
| 159 | Cerebral hemorrhage (HP:0001342) | 1.79261577 |
| 160 | Rapidly progressive (HP:0003678) | 1.78582940 |
| 161 | Glomerulonephritis (HP:0000099) | 1.78057460 |
| 162 | Impaired vibratory sensation (HP:0002495) | 1.77984877 |
| 163 | Tetraplegia (HP:0002445) | 1.77736120 |
| 164 | EEG with generalized epileptiform discharges (HP:0011198) | 1.77332440 |
| 165 | Absent speech (HP:0001344) | 1.72282090 |
| 166 | Abnormal EKG (HP:0003115) | 1.71007788 |
| 167 | Mild short stature (HP:0003502) | 1.69681944 |
| 168 | Narrow nasal bridge (HP:0000446) | 1.67707526 |
| 169 | Fetal akinesia sequence (HP:0001989) | 1.62649094 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.62145759 |
| 171 | Diminished motivation (HP:0000745) | 1.61708048 |
| 172 | CNS hypomyelination (HP:0003429) | 1.61182795 |
| 173 | Hypoplasia of the iris (HP:0007676) | 1.59229598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.54620925 |
| 2 | EPHA4 | 4.18584396 |
| 3 | DAPK2 | 3.86657210 |
| 4 | NTRK3 | 3.77425908 |
| 5 | MAP2K4 | 3.08721915 |
| 6 | MAP3K4 | 2.77561223 |
| 7 | MAP3K9 | 2.71824313 |
| 8 | UHMK1 | 2.66442996 |
| 9 | MAP3K12 | 2.56852571 |
| 10 | MAP2K7 | 2.53851160 |
| 11 | GRK5 | 2.36701956 |
| 12 | DAPK1 | 2.15310392 |
| 13 | MINK1 | 2.14893972 |
| 14 | KSR2 | 2.12312772 |
| 15 | PLK2 | 1.94680079 |
| 16 | BCKDK | 1.81411596 |
| 17 | PRKD3 | 1.81280149 |
| 18 | CDK19 | 1.74874084 |
| 19 | ARAF | 1.66701527 |
| 20 | RIPK4 | 1.66370149 |
| 21 | CCNB1 | 1.56107452 |
| 22 | PAK6 | 1.54077755 |
| 23 | RIPK1 | 1.46816122 |
| 24 | PTK2B | 1.45225643 |
| 25 | NTRK1 | 1.42736219 |
| 26 | TYRO3 | 1.39179744 |
| 27 | MAP3K2 | 1.33752128 |
| 28 | KSR1 | 1.33451366 |
| 29 | PRKCG | 1.32494138 |
| 30 | FGFR4 | 1.28853633 |
| 31 | PHKG2 | 1.25308359 |
| 32 | PHKG1 | 1.25308359 |
| 33 | SIK3 | 1.22106345 |
| 34 | DYRK1A | 1.19337578 |
| 35 | SIK1 | 1.18664017 |
| 36 | AKT3 | 1.16570195 |
| 37 | CAMKK1 | 1.16565221 |
| 38 | MARK2 | 1.10107603 |
| 39 | RET | 1.09415924 |
| 40 | MAP3K13 | 1.09116815 |
| 41 | PRPF4B | 1.07482811 |
| 42 | SGK223 | 1.05436933 |
| 43 | SGK494 | 1.05436933 |
| 44 | SGK2 | 1.04903901 |
| 45 | CAMK2A | 1.02921992 |
| 46 | LATS2 | 1.01639570 |
| 47 | CAMKK2 | 0.99874385 |
| 48 | CDK5 | 0.96588468 |
| 49 | MARK1 | 0.94637740 |
| 50 | DDR2 | 0.93963220 |
| 51 | PKN1 | 0.93097277 |
| 52 | FRK | 0.92261347 |
| 53 | INSRR | 0.90529946 |
| 54 | OXSR1 | 0.89595967 |
| 55 | MAPK12 | 0.88840888 |
| 56 | GRK6 | 0.83780155 |
| 57 | NTRK2 | 0.83481751 |
| 58 | MAP2K1 | 0.83420080 |
| 59 | CAMK1G | 0.83323874 |
| 60 | CAMK2B | 0.81410226 |
| 61 | MAP3K7 | 0.80263542 |
| 62 | FGFR2 | 0.79849976 |
| 63 | MAPK13 | 0.78686078 |
| 64 | SIK2 | 0.77458072 |
| 65 | FER | 0.77096250 |
| 66 | SGK3 | 0.73856735 |
| 67 | ICK | 0.73497473 |
| 68 | CAMK2G | 0.73382222 |
| 69 | TNIK | 0.71808287 |
| 70 | DAPK3 | 0.69906537 |
| 71 | PDPK1 | 0.69028866 |
| 72 | PRKCZ | 0.67642273 |
| 73 | MAP3K1 | 0.67423787 |
| 74 | DYRK2 | 0.67161479 |
| 75 | ERBB4 | 0.66868857 |
| 76 | BRAF | 0.65854425 |
| 77 | PINK1 | 0.65457267 |
| 78 | WNK1 | 0.63203551 |
| 79 | PDK1 | 0.62754459 |
| 80 | RAF1 | 0.62270993 |
| 81 | BMPR2 | 0.61782830 |
| 82 | MOS | 0.60641093 |
| 83 | ADRBK1 | 0.58907895 |
| 84 | CDK18 | 0.58622609 |
| 85 | MAPK10 | 0.57948366 |
| 86 | MAPK7 | 0.56932541 |
| 87 | BRSK1 | 0.56561267 |
| 88 | CDK14 | 0.56246107 |
| 89 | CAMK1D | 0.55643572 |
| 90 | RPS6KA3 | 0.55363850 |
| 91 | MAPK4 | 0.55278083 |
| 92 | CSNK1G2 | 0.53843777 |
| 93 | ALK | 0.52838730 |
| 94 | PAK3 | 0.52782912 |
| 95 | ROCK2 | 0.52060374 |
| 96 | EPHB2 | 0.52017490 |
| 97 | CDK15 | 0.51984682 |
| 98 | MST1R | 0.51212877 |
| 99 | NEK6 | 0.50855179 |
| 100 | FES | 0.50653183 |
| 101 | CAMK1 | 0.50233967 |
| 102 | NME1 | 0.49690452 |
| 103 | STK38 | 0.49437870 |
| 104 | FGR | 0.48497083 |
| 105 | CAMK4 | 0.47667648 |
| 106 | ABL2 | 0.46932208 |
| 107 | LIMK1 | 0.45492128 |
| 108 | DYRK1B | 0.44937998 |
| 109 | MAPKAPK5 | 0.44818488 |
| 110 | MAPK11 | 0.43687680 |
| 111 | PRKACG | 0.43408598 |
| 112 | SGK1 | 0.41779144 |
| 113 | ERN1 | 0.41651715 |
| 114 | PRKCE | 0.40989131 |
| 115 | LMTK2 | 0.40373658 |
| 116 | CDK11A | 0.40099096 |
| 117 | STK11 | 0.37198217 |
| 118 | JAK2 | 0.37069533 |
| 119 | PDK3 | 0.36700233 |
| 120 | PDK4 | 0.36700233 |
| 121 | PRKCA | 0.36130666 |
| 122 | PRKACA | 0.35771316 |
| 123 | PNCK | 0.35718041 |
| 124 | TESK1 | 0.35381573 |
| 125 | PRKCH | 0.35280217 |
| 126 | CAMK2D | 0.35035984 |
| 127 | PRKAA1 | 0.33663114 |
| 128 | MAP3K11 | 0.33494762 |
| 129 | PRKG1 | 0.32268426 |
| 130 | TRIB3 | 0.31812189 |
| 131 | MYLK | 0.31407246 |
| 132 | FYN | 0.30980171 |
| 133 | PRKCB | 0.29837062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.23213689 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.83144649 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39178636 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03657047 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.77430701 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55987145 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37159560 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37068552 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14481218 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88893899 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87413051 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84198779 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79986452 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73442016 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72625031 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72054310 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.67069005 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.66506177 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63170396 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.57962583 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57391967 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54441139 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54310541 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.53871945 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52553588 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51357472 |
| 27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51309736 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48572785 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.44382672 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44161556 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43724852 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38393186 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36263166 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.34977259 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34049333 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26493741 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25394061 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.24252127 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20904383 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20404748 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19313649 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18788756 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.17343005 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.14951316 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14709545 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14304423 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11815921 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08014212 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07774063 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07183656 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04931934 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04222792 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01514872 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00055567 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98633423 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95941075 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93130922 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.92524073 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91734786 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90718891 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90295597 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88049870 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87984446 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85009436 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84761008 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84455802 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84391613 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.83873030 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83734621 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83601373 |
| 71 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82959450 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82872355 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82777943 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77911717 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77763693 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74860375 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74452690 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74422736 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72804320 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70620233 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70368875 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70233001 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67404651 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67381782 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67208972 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65774507 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65247131 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64954478 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.64814137 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.62684082 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.62405125 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62171510 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.61236451 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61152212 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61056077 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60949628 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.60652716 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60465627 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57468886 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57027422 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56972856 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56463027 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56175539 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54882601 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.52394120 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51668440 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49101565 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48260875 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48147490 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46831909 |
| 111 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46256208 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.44652254 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44632829 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44450958 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44292736 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43491308 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42739820 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42420201 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42018922 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41417598 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39351251 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38629897 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37453384 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34726384 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34724828 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34700473 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34517878 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34065450 |
| 129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33340809 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.33299876 |
| 131 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32722335 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31172437 |
| 133 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.31013680 |
| 134 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30868374 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30519019 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30446252 |
| 137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29880474 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29823496 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29804281 |
| 140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29134272 |
| 141 | Long-term depression_Homo sapiens_hsa04730 | 0.28127345 |
| 142 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27720769 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27166960 |
| 144 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.27148872 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26599520 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24522723 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22548859 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22330788 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22313905 |
| 150 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21853520 |
| 151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21630678 |
| 152 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21511674 |
| 153 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20957603 |
| 154 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17782600 |

